Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$196M |
| 2 |
Verizon
VZ
|
+$166M |
| 3 |
Edison International
EIX
|
+$152M |
| 4 |
PPL
PPL Corp
PPL
|
+$122M |
| 5 |
Estee Lauder
EL
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ameren
AEE
|
+$140M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$136M |
| 3 |
ANDV
Andeavor
ANDV
|
+$111M |
| 4 |
LyondellBasell Industries
LYB
|
+$105M |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 15.65% |
| 2 | Healthcare | 13.77% |
| 3 | Energy | 13.48% |
| 4 | Utilities | 8.99% |
| 5 | Financials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MFA
2051
MFA Financial
MFA
$896M
| $1.31M | ﹤0.01% |
42,427
-190,523
| -82% | -$5.73M |
|
2052
PUT
Myriad Genetics
MYGN
$303M
| $1.31M | ﹤0.01% |
38,400
-261,600
| -87% | -$8.1M |
|
2053
Brinker International
EAT
$10B
| $1.31M | ﹤0.01% |
25,000
-62,387
| -71% | -$3.12M |
|
|
MRH
2054
DELISTED
MONTPELIER RE HOLDINGS LTD
MRH
| $1.31M | ﹤0.01% |
44,036
+19,650
| +81% | +$556K |
|
2055
iShares Russell 2000 ETF
IWM
$81.9B
| $1.3M | ﹤0.01% |
11,171
-81,059
| -88% | -$9.35M |
|
|
UCTT
2056
Ultra Clean Holdings
UCTT
$3.38B
| $1.3M | ﹤0.01% |
98,828
+61,406
| +164% | +$767K |
|
|
QCOR
2057
PUT
DELISTED
QUESTCOR PHARMA INC
QCOR
| $1.3M | ﹤0.01% |
20,000
| – | – |
|
2058
CVB Financial
CVBF
$3.92B
| $1.3M | ﹤0.01% |
+81,486
| New | +$1.29M |
|
2059
Baxter International
BAX
$13.4B
| $1.29M | ﹤0.01% |
32,402
-27,164
| -46% | -$1.02M |
|
|
AVP
2060
CALL
DELISTED
Avon Products, Inc.
AVP
| $1.29M | ﹤0.01% |
88,400
-16,700
| -16% | -$257K |
|
2061
Andersons Inc
ANDE
$2.17B
| $1.29M | ﹤0.01% |
21,815
+38
| +0.2% | +$2.13K |
|
2062
PUT
Bausch Health
BHC
$2.35B
| $1.29M | ﹤0.01% |
9,800
+3,600
| +58% | +$492K |
|
2063
Pixelworks
PXLW
$42.3M
| $1.29M | ﹤0.01% |
19,431
+14,002
| +258% | +$941K |
|
|
SWI
2064
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $1.29M | ﹤0.01% |
30,317
-45,700
| -60% | -$1.95M |
|
|
KBIO
2065
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
| $1.29M | ﹤0.01% |
59,532
+41,982
| +239% | +$1.22M |
|
2066
ProShares UltraPro S&P 500
UPRO
$5.61B
| $1.29M | ﹤0.01% |
+154,992
| New | +$1.21M |
|
2067
OSI Systems
OSIS
$3.36B
| $1.29M | ﹤0.01% |
+21,497
| New | +$1.29M |
|
2068
Erie Indemnity
ERIE
$13.6B
| $1.28M | ﹤0.01% |
18,418
+14,990
| +437% | +$1.05M |
|
2069
PUT
Amphenol
APH
$199B
| $1.28M | ﹤0.01% |
+112,000
| New | +$1.25M |
|
|
DRTX
2070
DELISTED
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
| $1.28M | ﹤0.01% |
95,167
-165,161
| -63% | -$2.16M |
|
2071
Cumberland Pharmaceuticals
CPIX
$131M
| $1.28M | ﹤0.01% |
+284,144
| New | +$1.35M |
|
2072
PUT
Southern Company
SO
$102B
| $1.28M | ﹤0.01% |
+29,100
| New | +$1.22M |
|
2073
PUT
Alaska Air
ALK
$4.71B
| $1.28M | ﹤0.01% |
27,400
+10,600
| +63% | +$439K |
|
|
EVOL
2074
DELISTED
Evolving Systems, Inc.
EVOL
| $1.28M | ﹤0.01% |
141,594
-1,900
| -1% | -$18K |
|
|
IO
2075
DELISTED
ION Geophysical Corporation
IO
| $1.27M | ﹤0.01% |
20,143
+5,398
| +37% | +$296K |
|
Similar funds
Israel Englander's Q1 2014 Portfolio in Review
As of Q1 2014, Israel Englander held 4,356 positions worth $34.5B, up 8.9% from $31.7B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Israel Englander deployed $4.18B of net new capital in Q1 2014, opening 945 new positions and adding to 1,266 existing holdings. Its largest new stake was Bausch Health: 575,504 shares worth $75.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 16% of assets, down from 25% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Ameren, an estimated $140M trimmed.
- Israel Englander's largest Q1 2014 buy was Bausch Health: 575,504 shares worth $75.9M.
- Israel Englander added most to Devon Energy in Q1 2014, an estimated $196M increase.
- Israel Englander's biggest Q1 2014 reduction was Ameren, cutting an estimated $140M.
- Israel Englander fully exited PepsiCo in Q1 2014, selling an estimated $89.1M.
- Israel Englander's ten largest holdings make up 7.9% of its $34.5B portfolio in Q1 2014.
- Israel Englander opened 945 new positions and closed 958 in Q1 2014.
- Israel Englander's portfolio value rose 8.9% quarter-over-quarter to $34.5B.
Based on Millennium Management's 13F filing for Q1 2014, filed 15 May 2014.